Clinical Trial Update: Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adding dexrazoxane to standard chemotherapy for newly diagnosed nonmetastatic osteosarcoma has completed. The study was sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• DEXRAZOXANE (DEXRAZOXANE)

Snippet

Sponsor: Children's Oncology Group | Conditions: Cardiac Toxicity, Sarcoma | Phase 3 | Status: COMPLETED